Convenience, compliance & control: How Insulet is changing insulin delivery tech

Shacey Petrovic spent nearly a decade trying to convince her diabetic father to switch to an insulin pump, rather than inject himself multiple times each day. But he was wary of the tubing and other challenges that come with constantly wearing a pump. So when Petrovic was tapped to serve as chief commercial officer at Insulet (NSDQ:PODD) in February 2015, she was eager to tell her dad about the company’s tubeless insulin delivery system, the Omnipod (Petrovic has since been promoted to president & COO of the Billerica, Mass.-based company). “He said, ‘I absolutely love it’,” Petrovic told Drug Delivery Business News. “I think if I had known about the Pod earlier, I would have been able to get him on to pump therapy much earlier.” Get the full story at our sister site, Drug Delivery Business News. The post Convenience, compliance & control: How Insulet is changing insulin delivery tech appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Drug Pumps Drug-Device Combinations Pharmaceuticals Wall Street Beat Amgen Bigfoot Biomedical Eli Lilly & Co. GlaxoSmithKline plc Insulet Medtronic Ypsomed Source Type: news